NCT06634004View on ClinicalTrials.gov

Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

September 11, 2029

Study Completion Date

September 11, 2030

Conditions
Moyamoya Disease
Interventions
OTHER

BOLD MRI

The study will utilize the MRI diagnostic reactivity test to evaluate cerebrovascular reactivity in patients with moyamoya and healthy controls. All participants (patients and controls) receive the same diagnostic scan, and there is no cross-over, factorial, or sequential nature to the study.

Trial Locations (2)

21218

Johns Hopkins University, Baltimore

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Vanderbilt University Medical Center

OTHER